Adagio Medical Holdings (ADGM) Non-Current Debt (2023 - 2024)
Adagio Medical Holdings' (ADGM) quarterly Non-Current Debt came in at $16.1 million in Q4 2024, down 57.99% year-over-year from $38.3 million in Q1 2024, and up 16.92% quarter-over-quarter from $13.8 million in Q3 2024.
Powered by 
Analysis
Adagio Medical Holdings (ADGM) Non-Current Debt (2023 - 2024) Analysis & Trends
Adagio Medical Holdings has disclosed Non-Current Debt across 2 years of filings, most recently posting $16.1 million for Q4 2024.
- In Q4 2024, Non-Current Debt fell 57.99% year-over-year to $16.1 million; the TTM figure through Dec 2024 stood at $16.1 million (down 57.99% YoY), while the FY2024 annual figure was $16.1 million, down 57.99% from the prior year.
- Non-Current Debt came in at $16.1 million for Q4 2024 at Adagio Medical Holdings, up from $13.8 million in the prior quarter.
- In the past five years, Non-Current Debt ranged from a high of $38.3 million in Q4 2023 to a low of $13.8 million in Q3 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | 29.60 Bn |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | - |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | 25.62 Bn |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | 14.19 Bn |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | 10.92 Bn |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | 598.70 Mn |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | -1.00 Mn |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | - |
| 9 | Steris | 21.90 Bn | 21.43 Bn | 684.20 Mn | 1.65 Bn |
| 10 | Adagio Medical Holdings | 12.44 Mn | 12.44 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | 16.08 Mn |
| Sep 30, 2024 | 13.75 Mn |
| Dec 31, 2023 | 38.27 Mn |